Novartis AG
DUS:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
DUS:NOT
|
CH |
|
F
|
Fast Retailing Co Ltd
F:FR70
|
JP |
|
D
|
Daikin Industries Ltd
OTC:DKILF
|
JP |
|
N
|
Nestle SA
XBER:NESR
|
CH |
|
C
|
Constellation Brands Inc
DUS:CB1A
|
US |
Wall St Price Targets
NOT Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOT is 135.29 EUR with a low forecast of 99.93 EUR and a high forecast of 159.83 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
135.29
EUR
According to Wall Street analysts, the average 1-year price target for NOT is 135.29 EUR with a low forecast of 99.93 EUR and a high forecast of 159.83 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
